## WMT: Walmart Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: PEG 4.24 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($112.15)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Walmart, Target Face FDA Heat After Recalled Baby Formula Tied To Infant Botulism Found In Stores**
- Source: Stocktwits | 20251215T184200 | Somewhat-Bearish | Relevance: 100%
- The FDA has issued letters to Walmart and Target after recalled ByHeart baby formula, linked to infant botulism, was found on their shelves. Both retailers have 15 working days to respond to the FDA regarding actions taken to address these violations. This comes after a multistate infant botulism outbreak traced to the ByHeart formula, which initiated a recall in early November.

**2. 76,672 Shares in Walmart Inc. $WMT Acquired by MASTERINVEST Kapitalanlage GmbH**
- Source: MarketBeat | 20251215T120824 | Somewhat-Bullish | Relevance: 100%
- MASTERINVEST Kapitalanlage GmbH initiated a new position in Walmart Inc. (NASDAQ:WMT) during the second quarter, acquiring 76,672 shares valued at approximately $7,497,000. Other institutional investors also adjusted their holdings in Walmart, contributing to the 26.76% institutional ownership of the company. Walmart recently reported strong quarterly earnings, beating analyst estimates with $0.62 EPS and $179.50 billion in revenue, and analysts have set a consensus "Moderate Buy" rating with a target price of $119.31 for the stock.

**3. N.E.W. Advisory Services LLC Sells 15,064 Shares of Walmart Inc. $WMT**
- Source: MarketBeat | 20251214T112716 | Somewhat-Bullish | Relevance: 100%
- N.E.W. Advisory Services LLC has reduced its stake in Walmart Inc. by selling 15,064 shares, retaining 13,932 shares valued at approximately $1.36 million. This divestment comes as Walmart reported strong quarterly earnings, surpassing analyst estimates, and offered positive FY2026 EPS guidance. While analysts maintain a "Moderate Buy" rating for the stock, company insiders have recently been net sellers of Walmart shares.

**4. Castleark Management LLC Sells 18,540 Shares of Walmart Inc. $WMT**
- Source: MarketBeat | 20251214T095410 | Somewhat-Bullish | Relevance: 100%
- Castleark Management LLC reduced its stake in Walmart Inc. by 17.8% during the second quarter, selling 18,540 shares and retaining 85,500 shares valued at approximately $8.36 million. Despite insider selling, Wall Street maintains a "Moderate Buy" rating for Walmart with an average price target of $119.31, following the company's recent strong quarterly performance and positive FY2026 guidance.

**5. Walmart Inc. Common Stock (WMT) Formally Relocates On NASDAQ**
- Source: Insider Monkey | 20251213T124100 | Bullish | Relevance: 100%
- Walmart Inc. (NASDAQ: WMT) officially moved its primary stock listing from the NYSE to Nasdaq on December 9, 2025, retaining its "WMT" symbol. This strategic relocation, viewed as highly significant, signals Walmart's commitment to being a technologically advanced omnichannel retailer, reinforced by its recent "beat & raise" report and a Buy rating from Jefferies with a $125 price target. The company's CEO, Doug McMillon, highlighted advancements in AI and e-commerce as key drivers for the switch, with Walmart integrating AI into its operations, advertising, and customer experience, resulting in a 25.76% YTD stock increase.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 16, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Evercore ISI Gr | $117 | $115 | +2% |
| 2025-12-03 | Tigress Financi | $130 | $125 | +4% |
| 2025-11-21 | JP Morgan | $129 | $128 | +1% |
| 2025-11-21 | DA Davidson | $130 | $117 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Evercore ISI Gr | main | Outperform |
| 2025-12-03 | Tigress Financi | main | Buy |
| 2025-11-21 | JP Morgan | main | Overweight |
| 2025-11-21 | DA Davidson | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.34M) |
| Sells | 29 ($13.28M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 19.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 5.5% (+0.9%)
- Blackrock Inc.: 4.3% (+0.4%)
- JPMORGAN CHASE & CO: 2.9% (+137.3%)
- State Street Corpora: 2.3% (+1.2%)
- Geode Capital Manage: 1.2% (+2.0%)

### Key Risks

1. Heavy insider selling: $13M sold (29 transactions in 90 days).
2. Valuation stretched: PEG 4.2x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 16 raises (avg +7%) could attract flows.
- Momentum building: MRS_10 improving +2.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 4.24 signals overvaluation risk, limited margin of safety. Forward P/E 39.2x stretched relative to 13% growth. Quality metrics strong (ROE 24%). Analyst sentiment positive (16 raises, avg +7%). Insider selling cluster ($13.3M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $931.1B |
| Beta | 0.64 |
| 52W Range | $79.81 - $117.45 |
| Short Interest | 0.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.24 |
| Forward P/E | 39.2 |
| Current P/E | 44.3 |
| YoY Growth | 13.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 1.6% to 3.7% (+2.1% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 70th percentile. MRS_5 at 2.8% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -DLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.69% (CS: 71) | Strong |
| RSI_14 | 69.7 | Neutral |
| MACD Histogram | 0.49 | Bullish |
| vs SMA20 | 1.058x | Above |
| vs SMA50 | 1.097x | Above |
| vs SMA200 | 1.182x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $116.79
- **Stop Loss:** $112.15 (4.0% risk)
- **Target:** $121.43 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 258
- **Position Value:** $30,131.82
- **Portfolio %:** 30.13%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-19 (Est: $0.72)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.60 | $0.62 | +3.1% |
| 2025Q3 | $0.74 | $0.68 | -8.0% |
| 2025Q2 | $0.58 | $0.61 | +5.6% |
| 2025Q1 | $0.65 | $0.66 | +2.0% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*